Vincent Gasparik
Strasbourg, 67000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.
Journal: Journal of medicinal chemistry
Published: August 15, 2018
Probing the Outstanding Local Hydrophobicity Increases in Peptide Sequences Induced by Incorporation of Trifluoromethylated Amino Acids.
Journal: Chembiochem : a European journal of chemical biology
Published: February 12, 2018
From the Promiscuous Asenapine to Potent Fluorescent Ligands Acting at a Series of Aminergic G-Protein-Coupled Receptors.
Journal: Journal of medicinal chemistry
Published: December 09, 2017
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.
Journal: Journal of medicinal chemistry
Published: December 19, 2014
A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.
A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 03, 2013
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice.
Journal: The Journal of biological chemistry
Published: March 02, 2013
Methylation of imidazoline related compounds leads to loss of α₂-adrenoceptor affinity. Synthesis and biological evaluation of selective I₁ imidazoline receptor ligands.
Journal: Bioorganic & medicinal chemistry
Published: March 23, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026